A Two Comparator, Controlled Phase 3 Study in Patients With and Without Evaporative Dry Eye
Status:
Completed
Trial end date:
2017-09-18
Target enrollment:
Participant gender:
Summary
Omega 3 (OM3) Tear is a new unit dose emulsion, containing flaxseed/castor oil, which is
being developed by Allergan. It is desirable to understand the effect that this new emulsion
has on tear film evaporation and tear lipid profile via interferometry, in patients with
evaporative dry eye (EDE) and those without (non-EDE). It would also be valuable to evaluate
the retention time of the lipid components of the new emulsion via tear collection and
analysis in EDE and non-EDE patients